The TIDES Europe conference agenda is designed with scientific tracks that delve into comprehensive discovery, development, and manufacturing strategies. These sessions will explore emerging trends and technologies across the entire spectrum of oligonucleotide and peptide modalities, covering a broad range of critical areas.
Specifically, the program addresses oligonucleotide chemistry, manufacturing, and controls, focusing on CMC, analytical, manufacturing, and regulatory strategies to accelerate product development. It also covers oligonucleotide discovery, preclinical, and clinical aspects, aimed at designing molecules with improved drug-like properties. For peptides, tracks will enhance process efficiencies and address challenges in chemistry, manufacturing, and controls, while also exploring new frontiers in discovery, design, and engineering to optimize targeting and delivery. Furthermore, the agenda includes updates on mRNA therapeutics and genome editing, along with discussions on macromolecular drug delivery technologies to overcome challenges in delivering oligonucleotides, peptides, mRNA, and other large molecules.
